查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年消融技術市場預測 - 按產品、技術、用途、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1340008

2030 年消融技術市場預測 - 按產品、技術、用途、最終用戶和地區進行的全球分析

Ablation Technology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球消融技術市場規模將達到 84.9 億美元，預計到 2030 年將達到 208.5 億美元，預測期內年複合成長率為 13.7%。

消融通常是指手術切除一部分活組織。與肝癌、腎癌、前列腺癌和肺癌的傳統手術治療相比，這種治療提供了一種侵入性較小的選擇。這是一種微創手術，比傳統外科手術痛苦更少，恢復時間也更快。

根據 2021 年 2 月更新的 RadiologyInfo.org報導，射頻消融 (RFA) 是一種癌症微創治療方法，採用圖像引導技術，通過加熱來破壞癌細胞。

市場動態：

促進因素：

  • 醫院成為強大的最終用戶，提供更好的患者照護。
  • 由於擁有訓練有素的醫療專業人員和最先進的設備，醫院消融手術的發生率明顯更高，從而降低了手術的複雜性。此外，消融領域新產品的推出以及政府為加強醫院基礎設施而增加的資金預計也將支持市場成長。

抑制因素：

  • 高產品成本阻礙成長。
  • 治療費用根據患者的年齡和嚴重程度而有所不同。在印度，導管消融費用約為 1-1.25 盧比。費用因醫院和外科醫生而異。 Eckard 等人在決策分析模型中估計，每個品質調整生命年的消融成本約為 58,000 美元。該成本估算並未假設消融可以預防中風。因此，全球消融技術市場的擴張可能會受到其高價格的限制。

機會：

  • 對非侵入性和微創技術的需求不斷增加。
  • 與傳統治療方法相比，它具有手術合併少、住院時間短、疼痛少、切口小、美觀、感染風險低、術後護理少、恢復快等優點，因此對微創的需求日益凸顯。手續明顯增多。最新技術用於微創手術來識別和治療癌症等疾病。這些技術用於去除淋巴結和癌症腫瘤而不留下疤痕。外科醫生還可以藉助微創手術採集樣本進行活體組織切片和詳細的分期測試。

威脅：

  • 舊技術的再利用和加工。
  • 根據 FDA 和歐盟法規，消融導管被歸類為拋棄式設備 (SUD)。然而，由於每瓶成本高且報銷低，資金短缺的醫院正在轉向再加工和再利用。與新型消融設備的價格相比，醫院和手術中心將花費不到10%的再處理和再利用成本，從而將手術的總體成本降低約50%。德國是歐洲允許重複使用 SUD（包括消融導管）的主要國家之一，前提是這些設備按照法規標準重複使用。

COVID-19 的影響：

  • COVID-19 的爆發給醫療保健行業造成了重大障礙。由於大多數慢性護理被認為是非緊急的，因此在 COVID-19 爆發期間所有門診護理都被推遲或限制，以降低病毒感染的風險。例如，根據 2022 年 11 月 PubMed 發表的一份報告，導管消融（CA）在 COVID-19 大流行初期急劇下降，然後逐漸恢復到 COVID-19 之前的水平。在此期間完成的消融手術數量明顯低於往年，因為所有非緊急擇期手術均因 COVID-19 大流行而被取消。
  • 預計在預測期內，癌症治療行業將是最大的。
  • 由於全球癌症患者數量不斷增加，癌症治療領域在預測期內佔據了最大的市場佔有率。對於小腫瘤，射頻治療是最流行的消融技術之一。它使用特殊的探針來“烘烤”或“冷凍”腫瘤，而不需要傳統的手術。然後使用磁振造影(MRI)、超音波或電腦斷層掃描 (CT) 引導針探針並將其放置在腫瘤內。例如，IARC 預測，到 2040 年，全球將新增 2890 萬癌症病例。
  • 高頻消融行業預計在預測期內年複合成長率最高
  • 在醫療保健領域擴大使用尖端射頻（RF）技術以及主要市場參與企業這一目標將會實現。這推動了對射頻消融器的需求。此外，當與合適的多通道射頻發生器結合使用時，它可以實現心房心臟消融和基於導管的心臟電生理圖測。

佔比最高的地區

由於研發 (R&D) 的改進以及擴大採用新技術來設計有效的消融產品，預計北美將在估計期間佔據最大的市場佔有率。此外，在消融設備製造中使用更先進的方法和系統，消融設備研究的技術發展預計將推動北美地區的市場擴張。

複合年複合成長率最高的地區：

由於癌症和心臟病的患病率和發病率不斷上升、消融產品和技術的技術進步、人們對微創技術的認知不斷增強以及新興市場的成長機會，亞太地區有望在估計期間實現良好的成長。此外，受慢性病罹患的龐大人口以及對快速識別和治療這些疾病的消融設備不斷成長的需求也將推動該地區消融設備市場的擴張。

免費客製化服務：

訂閱此報告的客戶將收到以下免費客製化選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（注：基於可行性檢查）
  • 競爭標杆管理
    • 根據產品系列、地域分佈和戰略聯盟對主要企業進行基準測試

目錄

第1章 執行摘要

第2章 前言

  • 執行摘要
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 資料挖掘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球消融技術市場：副產品

  • 冷凍消融裝置
  • 電燒灼
  • 水熱/水力機械消融器
  • 雷射/光學燒蝕機
  • 微波消融儀
  • 高頻燒蝕機
  • 超音波消融儀
  • 其他產品

第6章 全球消融技術市場：按技術分類

  • 熱消融技術
    • 超音波消融
    • 光學消融
    • 放射消融
    • 水熱消融
    • 微波
    • 電消融
  • 非熱消融技術
    • 流體力學
    • 冷凍消融
  • 其他技術

第7章 全球消融技術市場：按用途

  • 心血管疾病治療
  • 癌症治療
  • 婦科治療
  • 整容手術
  • 疼痛管理
  • 整形外科治療
  • 泌尿外科治療
  • 眼科治療
  • 其他用途

第8章 全球消融技術市場：按最終用戶分類

  • 門診手術中心
  • 醫院和消融中心
  • 醫療水療和美容診所
  • 其他最終用戶

第9章 全球消融技術市場：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 契約、夥伴關係、聯盟和合資企業
  • 收購和合併
  • 新產品上市
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Johnson & Johnson
  • Smith & Nephew PLC
  • Abbott Laboratories
  • Smith & Nephew plc
  • Boston Scientific
  • Olympus Corporation
  • Medtronic
  • Varian Medical Systems
  • AngioDynamics, Inc
  • Dornier MedTech
  • AtriCure, Inc.
  • Alcon Laboratories
Product Code: SMRC23715

According to Stratistics MRC, the Global Ablation Technology Market is accounted for $8.49 billion in 2023 and is expected to reach $20.85 billion by 2030 growing at a CAGR of 13.7% during the forecast period. Ablation usually refers to the surgical removal of a portion of biological tissue. The procedure's devices offer a less intrusive option to traditional surgical treatment for liver, kidney, prostate, and lung cancer. It takes less time to recover because it is a minimally invasive technique and less painful than traditional surgical procedures.

According to an article by RadiologyInfo.org updated in February 2021, radiofrequency ablation (RFA), a minimally invasive treatment for cancer, employs an image-guided technique to apply heat to destroy cancer cells.

Market Dynamics:

Driver:

  • Hospitals will become a prominent end-user with better patient care.
  • Hospital settings have a significantly higher incidence rate of ablation operations because these facilities guarantee the availability of trained medical professionals and cutting-edge equipment, which reduces the complexity of the procedure. Additionally, market growth will also be aided by the introduction of novel products in the ablation sector and increased government funding for enhancing hospital infrastructure.

Restraint:

  • High product costs inhibit growth.
  • Depending on the patient's age and severity, the cost of the treatment varies. Catheter ablation will cost approximately 1-1.25 lakh rupees in India. The cost may vary according to the hospital, the surgeon, etc. Eckard et al. estimated the cost of ablation in a decision-analytic model to be about USD 58,000 per quality-adjusted life year. This cost is forecast without assuming that the ablation approach will prevent strokes. Therefore, the worldwide ablation technology market's expansion may be constrained by its expensive price.

Opportunity:

  • Growing demand for non-invasive and minimally-invasive techniques.
  • Due to the benefits that these procedures offer over conventional treatment methods fewer operative complications, fewer hospital stays, less pain, smaller and more aesthetic incisions, lower risk of infection, reduced post-operative care, and a faster recovery-the demand for minimally invasive procedures has increased significantly. Modern technology is used in minimally invasive procedures to identify and treat diseases like cancer. These techniques are used to remove lymph nodes and cancerous tumors without leaving wounds. Surgeons can also collect samples for biopsies and precise staging tests with the help of minimally invasive procedures.

Threat:

  • Reusing and processing old technology.
  • Ablation catheters are classified as single-use devices (SUDs) under FDA and EU regulations. Hospitals with limited funds, however, are switching to reprocessing and reuse because of the high per-unit cost and low reimbursement. In comparison to the price of a new ablation device, the cost incurred by a hospital or surgical center for reprocessing and reuse is less than 10%, cutting the whole procedure cost by about 50%. Under the condition that the devices are recycled in accordance with regulatory criteria, Germany is one of the major European nations that permits the reuse of SUDs (including ablation catheters).

COVID-19 Impact:

  • The COVID-19 epidemic posed significant hurdles for the healthcare sector. Since the majority of chronic therapy was considered non-urgent, all outpatient treatments were delayed or restricted during the COVID-19 pandemic in order to lower the danger of viral transmission. For instance, according to a report published in November 2022 in PubMed, catheter ablation (CA) drastically collapsed in the early stages of the COVID-19 pandemic before gradually recovering to pre-COVID-19 levels. The number of ablation surgeries accomplished during the period is significantly less than that of the prior year due to the COVID-19 pandemic's suspension of all non-urgent elective surgical procedures.
  • The cancer treatment segment is expected to be the largest during the forecast period.
  • Due to the increasing number of cancer patients worldwide, the Cancer Treatment segment held the largest market share over the projection period. For small tumors, radiofrequency treatment is one of the most popular ablation techniques. Without the need for traditional surgery, special probes are utilized to "burn" or "freeze" tumors. Additionally, the needle probe is guided and positioned into the tumor using magnetic resonance imaging (MRI), ultrasound, or computed tomography (CT). For instance, the IARC predicts that there will be 28.9 million new instances of cancer worldwide by 2040.
  • The radiofrequency ablators segment is expected to have the highest CAGR during the forecast period
  • Owing to the increasing use of cutting-edge Radio Frequency (RF) technologies in healthcare as well as the introduction of new products into the market by major market players, the radiofrequency ablators segment is predicted to grow profitably throughout the dominance period. This is driving up demand for radiofrequency ablators. Additionally, when used in combination with a suitable multi-channel RF generator, it is permitted for cardiac ablation and catheter-based cardiac electrophysiology mapping of the atria.

Region with largest share:

Due to improved Research and Development (R&D) for the design of effective ablation products and increasing adoption of new technologies, North America is predicted to hold the largest market share throughout the extrapolated period. Furthermore, the use of more advanced methods and systems in the production of ablation devices, as well as technological developments in ablation device research, are anticipated to drive the market's expansion in the North American region.

Region with highest CAGR:

Due to the increasing prevalence and incidence of cancer and cardiac conditions, technological advancements in ablation products and technology, growing awareness of minimally invasive techniques, and growth opportunities in emerging markets, the Asia-Pacific region commanded lucrative growth during the estimated period. Moreover, the enormous populations affected by chronic diseases and the growing need for ablation devices for rapid identification and treatment of these diseases are also anticipated to fuel the ablation device market's expansion in the region.

Key players in the market:

Some of the key players in Ablation Technology market include: Johnson & Johnson, Smith & Nephew PLC, Abbott Laboratories, Smith & Nephew plc, Boston Scientific, Olympus Corporation, Medtronic, Varian Medical Systems, AngioDynamics, Inc, Dornier MedTech, AtriCure, Inc. and Alcon Laboratories.

Key Developments:

  • In October 2022, The C2 CryoBalloon Ablation System was released in Canada to treat Barrett's Esophagus. This was done by PENTAX Medical, a company in the healthcare industry that makes diagnostic and therapeutic endoscopy solutions.
  • In March 2022, Quantum Surgical received 510(k) clearance from the United States Food and Drug Administration for the Epione robot, which can plan, target, deliver, and confirm tumor ablation for cancer treatment.
  • In January 2022, Medtronic plc entered into a definitive agreement to acquire Affera, Inc. The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.
  • In January 2022, Affera, a provider of medical technology, reached a formal agreement under which Medtronic will acquire the company for USD 925 million. Through its portfolio of minority investments, Medtronic has been a strategic investor in Affera and now has a 3% stake in the company.

Products Covered:

  • Cryoablation Devices
  • Electrical Ablators
  • Hydrothermal/Hydromechanical Ablators
  • Laser/Light Ablators
  • Microwave Ablators
  • Radiofrequency Ablators
  • Ultrasound Ablators
  • Other Products

Technologies Covered:

  • Thermal ablation technology
  • Non-thermal ablation technology
  • Other Technologies

Applications Covered:

  • Cardiovascular Disease Treatment
  • Cancer Treatment
  • Gynecological Treatment
  • Cosmetic/ Aesthetic Surgery
  • Pain Management
  • Orthopedic Treatment
  • Urological Treatment
  • Ophthalmologic Treatment
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals and ablation centers
  • Medical Spas & Aesthetic clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ablation Technology Market, By Product

  • 5.1 Introduction
  • 5.2 Cryoablation Devices
  • 5.3 Electrical Ablators
  • 5.4 Hydrothermal/Hydromechanical Ablators
  • 5.5 Laser/Light Ablators
  • 5.6 Microwave Ablators
  • 5.7 Radiofrequency Ablators
  • 5.8 Ultrasound Ablators
  • 5.9 Other Products

6 Global Ablation Technology Market, By Technology

  • 6.1 Introduction
  • 6.2 Thermal Ablation Technology
    • 6.2.1 Ultrasound Ablation
    • 6.2.2 Light Ablation
    • 6.2.3 Radiation Ablation
    • 6.2.4 Hydrothermal Ablation
    • 6.2.5 Microwave
    • 6.2.6 Electrical Ablation
  • 6.3 Non-thermal Ablation Technology
    • 6.3.1 Hydromechanical
    • 6.3.2 Cryoablation
  • 6.4 Other Technologies

7 Global Ablation Technology Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiovascular Disease Treatment
  • 7.3 Cancer Treatment
  • 7.4 Gynecological Treatment
  • 7.5 Cosmetic/ Aesthetic Surgery
  • 7.6 Pain Management
  • 7.7 Orthopedic Treatment
  • 7.8 Urological Treatment
  • 7.9 Ophthalmologic Treatment
  • 7.10 Other Applications

8 Global Ablation Technology Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals and Ablation Centers
  • 8.4 Medical Spas & Aesthetic Clinics
  • 8.5 Other End Users

9 Global Ablation Technology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Johnson & Johnson
  • 11.2 Smith & Nephew PLC
  • 11.3 Abbott Laboratories
  • 11.4 Smith & Nephew plc
  • 11.5 Boston Scientific
  • 11.6 Olympus Corporation
  • 11.7 Medtronic
  • 11.8 Varian Medical Systems
  • 11.9 AngioDynamics, Inc
  • 11.10 Dornier MedTech
  • 11.11 AtriCure, Inc.
  • 11.12 Alcon Laboratories

List of Tables

  • Table 1 Global Ablation Technology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Ablation Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Ablation Technology Market Outlook, By Cryoablation Devices (2021-2030) ($MN)
  • Table 4 Global Ablation Technology Market Outlook, By Electrical Ablators (2021-2030) ($MN)
  • Table 5 Global Ablation Technology Market Outlook, By Hydrothermal/Hydromechanical Ablators (2021-2030) ($MN)
  • Table 6 Global Ablation Technology Market Outlook, By Laser/Light Ablators (2021-2030) ($MN)
  • Table 7 Global Ablation Technology Market Outlook, By Microwave Ablators (2021-2030) ($MN)
  • Table 8 Global Ablation Technology Market Outlook, By Radiofrequency Ablators (2021-2030) ($MN)
  • Table 9 Global Ablation Technology Market Outlook, By Ultrasound Ablators (2021-2030) ($MN)
  • Table 10 Global Ablation Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 11 Global Ablation Technology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Ablation Technology Market Outlook, By Thermal Ablation Technology (2021-2030) ($MN)
  • Table 13 Global Ablation Technology Market Outlook, By Ultrasound Ablation (2021-2030) ($MN)
  • Table 14 Global Ablation Technology Market Outlook, By Light Ablation (2021-2030) ($MN)
  • Table 15 Global Ablation Technology Market Outlook, By Radiation Ablation (2021-2030) ($MN)
  • Table 16 Global Ablation Technology Market Outlook, By Hydrothermal Ablation (2021-2030) ($MN)
  • Table 17 Global Ablation Technology Market Outlook, By Microwave (2021-2030) ($MN)
  • Table 18 Global Ablation Technology Market Outlook, By Electrical Ablation (2021-2030) ($MN)
  • Table 19 Global Ablation Technology Market Outlook, By Non-Thermal Ablation Technology (2021-2030) ($MN)
  • Table 20 Global Ablation Technology Market Outlook, By Hydromechanical (2021-2030) ($MN)
  • Table 21 Global Ablation Technology Market Outlook, By Cryoablation (2021-2030) ($MN)
  • Table 22 Global Ablation Technology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 23 Global Ablation Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 Global Ablation Technology Market Outlook, By Cardiovascular Disease Treatment (2021-2030) ($MN)
  • Table 25 Global Ablation Technology Market Outlook, By Cancer Treatment (2021-2030) ($MN)
  • Table 26 Global Ablation Technology Market Outlook, By Gynecological Treatment (2021-2030) ($MN)
  • Table 27 Global Ablation Technology Market Outlook, By Cosmetic/ Aesthetic Surgery (2021-2030) ($MN)
  • Table 28 Global Ablation Technology Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 29 Global Ablation Technology Market Outlook, By Orthopedic Treatment (2021-2030) ($MN)
  • Table 30 Global Ablation Technology Market Outlook, By Urological Treatment (2021-2030) ($MN)
  • Table 31 Global Ablation Technology Market Outlook, By Ophthalmologic Treatment (2021-2030) ($MN)
  • Table 32 Global Ablation Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 Global Ablation Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Global Ablation Technology Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 35 Global Ablation Technology Market Outlook, By Hospitals and Ablation Centers (2021-2030) ($MN)
  • Table 36 Global Ablation Technology Market Outlook, By Medical Spas & Aesthetic Clinics (2021-2030) ($MN)
  • Table 37 Global Ablation Technology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.